A new study from the USC Norris Comprehensive Cancer Center has found evidence that targeting CD47, a protein that is part of ...

The most important takeaway from the study is that these data suggest that CD47 is an attractive target for drug development.

From James Van Der Beek spreading awareness about colorectal cancer at a younger age to Gerry Connolly’s recent esophageal ...

Three monoclonal antibodies (cetuximab, bevacizumab and panitumumab) have been approved for the treatment of colorectal cancer in the USA and a large number of other monoclonal antibodies are ...

A technological breakthrough by medical researchers at Tel Aviv University enabled the discovery of a cancer mechanism that ...

James Van Der Beek is attempting to remain in good spirits as he battles stage 3 colorectal cancer. The "Dawson’s Creek" star opened up about the challenges he has faced during his cancer journey. Van ...

For rectal cancer, treatment may include options like chemotherapy, radiation, surgery and immunotherapy, according to the ...

What is it and what are the symptoms? - James Van Der Beek shares six children with his wife Kimberly Van Der Beek ...

The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation. Patients with active disease also had greater abundance of clusters of ...

In studies using mouse models of advanced colorectal cancer and melanoma ... "Probiotic neoantigen delivery vectors for precision cancer immunotherapy." All authors: Andrew Redenti, Jongwon ...

Updated clinical data from VISTA101 presented at SITC 2024.Monotherapy arm fully enrolled and combination arm expected to be fully enrolled by ...

Three monoclonal antibodies (cetuximab, bevacizumab and panitumumab) have been approved for the treatment of colorectal cancer in the USA and a large number of other monoclonal antibodies are ...